Skip to main content

Want a detailed portfolio tracker?

Psyence Biomedical (PBM) P/E (2025 - 2026)

Psyence Biomedical (PBM) P/E from Sep 30, 2025 to Jul 21, 2026. The TTM Psyence Biomedical (PBM) P/E is -8.55. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Psyence Biomedical (PBM)

YearP/EChange
2026-8.55-89.43%
2025-80.92N/A

Comparison Psyence Biomedical (PBM) P/E with competitors

Psyence Biomedical (PBM) P/E is -8.55.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.87%
FGENFibroGen Inc0.24-102.81%
CHRSCoherus Biosciences Inc0.85-109.92%
FBIOFortress Biotech Inc0.95-111.10%
ORMPOramed Pharmaceuticals Inc1.50-117.58%
AGENAgenus Inc3.01-135.19%
INVAInnoviva Inc3.15-136.88%
VXRTVaxart Inc3.55-141.51%
CRMDCorMedix Inc3.63-142.43%
CVACCureVac N.V.4.45-151.98%
GLPGGalapagos NV4.86-156.82%
SRPTSarepta Therapeutics Inc4.88-157.09%
ABEOAbeona Therapeutics Inc5.39-163.00%
ABUSArbutus Biopharma Corp5.60-165.43%
ZVRAZevra Therapeutics Inc5.89-168.84%
SPROSpero Therapeutics Inc6.23-172.83%
CGENCompugen Ltd6.31-173.83%
RIGLRigel Pharmaceuticals6.87-180.36%
SLXNSilexion Therapeutics Corp7.30-185.31%
OMEROmeros Corporation9.26-208.26%
AUPHAurinia Pharmaceuticals Inc9.58-212.08%
PLXProtalix BioTherapeutics Inc10.89-227.35%
ACADAcadia Pharmaceuticals Inc11.73-237.14%
TBPHTheravance Biopharma Inc12.26-243.38%
ADMAAdma Biologics Inc12.42-245.21%
HRMYHarmony Biosciences Holdings Inc13.82-261.60%
SABSSAB Biotherapeutics Inc14.14-265.30%
NAGENiagen Bioscience Inc14.82-273.27%
INCYIncyte Corp15.82-285.02%
REGNRegeneron Pharmaceuticals Inc15.86-285.42%
CPRXCatalyst Pharmaceuticals Inc17.44-303.92%
EXELExelixis Inc17.54-305.08%
TGTXTG Therapeutics Inc18.97-321.78%
MDXGMimedx Group Inc20.55-340.33%
XOMAXOMA Royalty Corp22.87-367.49%
ARGXArgen X SE24.30-384.13%
CTMXCytomX Therapeutics Inc24.82-390.25%
XOMAOXOMA Royalty Corp25.34-396.37%
HALOHalozyme Therapeutics Inc25.62-399.63%
XOMAPXOMA Royalty Corp25.67-400.18%
VRTXVertex Pharmaceuticals Inc27.99-427.36%
RPRXRoyalty Pharma plc - Class A28.69-435.46%
SLNOSoleno Therapeutics Inc29.02-439.29%
ASNDAscendis Pharma A/S30.09-451.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-543.33%
APLSApellis Pharmaceuticals Inc39.02-556.30%
BMRNBiomarin Pharmaceutical Inc42.21-593.61%
KRYSKrystal Biotech Inc45.34-630.23%
ONCBeiGene Ltd69.54-913.18%
PHARPharming Group N.V.75.03-977.32%
TECHBio-Techne Corp101.96-1292.26%
VCELVericel Corp109.92-1385.38%
ALNYAlnylam Pharmaceuticals Inc117.96-1479.44%
GMABGenmab140.29-1740.50%
TLXTelix Pharmaceuticals Ltd162.15-1996.15%
CORTCorcept Therapeutics Inc212.86-2589.07%